Introduction Executive Summary Antisense Oligonucleotide Therapeutics: Overview • Causes • Mechanism of Action • Signs and Symptoms • Diagnosis • Disease Management Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Late Stage Products (Phase III) • Comparative Analysis Cobitolimod: InDex Pharmaceuticals • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis Prexigebersen: Bio-Path Holdings • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early stage products (Phase I/II) • Comparative Analysis ALG-020572: Aligos Therapeutics • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Antisense Oligonucleotide Therapeutics Key Companies Antisense Oligonucleotide Therapeutics Key Products Antisense Oligonucleotide Therapeutics- Unmet Needs Antisense Oligonucleotide Therapeutics- Market Drivers and Barriers Antisense Oligonucleotide Therapeutics- Future Perspectives and Conclusion Antisense Oligonucleotide Therapeutics Analyst Views Antisense Oligonucleotide Therapeutics Key Companies Appendix

Table 1 Total Products for Antisense Oligonucleotide Therapeutics Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Ionis Pharmaceuticals • Secarna Pharmaceuticals • Aro Biotherapeutics • NeuBase Therapeutics • Bio-Path Holdings, Inc. • Scopus Biopharma • Dyne Therapeutics • CAMP4 Therapeutics • Pulmotect • GeneTx Biotherapeutics • Aligos Therapeutics • WaVe life Sciences